Group 1 - The A-share market saw a strong performance in the film sector, with notable stocks such as Baida Qiancheng hitting a 20% limit up, Jinyi Film reaching a 10% limit up, and Huayi Brothers increasing by over 8% [1] - As of December 28, 2025, the total box office for China's New Year film season has surpassed 5 billion yuan, marking the highest figure for the same period in nearly eight years [1] Group 2 - Baida Qiancheng's stock increased by 19.94%, with a total market value of 7.309 billion yuan and a year-to-date increase of 54.27% [2] - Jinyi Film's stock rose by 10.04%, with a market capitalization of 4.373 billion yuan and a year-to-date increase of 47.46% [2] - Huayi Brothers experienced an 8.88% increase, with a market value of 6.465 billion yuan, but a year-to-date decline of 11.07% [2] - Other notable stocks include Xingfu Lanhai with a 5.79% increase and a market value of 7.825 billion yuan, and Hengdian Film with a 5.52% increase and a market capitalization of 10.6 billion yuan [2]

Core Viewpoint - The A-share market is experiencing a strong performance in the film sector, with several companies seeing significant stock price increases as the Chinese film box office for the 2025 New Year’s release period surpasses 5 billion yuan, marking the highest level in nearly eight years for the same period [1] Group 1: Company Performance - Baina Qiancheng's stock hit the daily limit of 20%, indicating strong investor interest [1] - Jinyi Film's stock increased by 10%, reflecting positive market sentiment [1] - Huayi Brothers' stock rose over 8%, contributing to the overall strength of the film sector [1] - Happiness Blue Sea and Hengdian Film's stocks both increased by over 5%, showcasing a broad rally in the industry [1] - Bona Film's stock rose by over 4%, further indicating a positive trend in the market [1] Group 2: Industry Insights - As of December 28, the total box office for the 2025 Chinese film New Year period has exceeded 5 billion yuan, setting a new record for the highest box office in nearly eight years for this timeframe [1]

Group 1 - The film industry sector experienced a significant rise in early trading, with notable stocks such as Baina Qiancheng hitting a 20% limit up, Huayi Brothers increasing over 10%, and Jinyi Films rising over 8% [1] - As of December 28, 2025, the total box office for the New Year’s film season reached 5.245 billion yuan, marking the second time in Chinese film history that the New Year’s box office has surpassed 5 billion yuan since 2017, and achieving the highest box office for this period in nearly eight years [2] Group 2 - The State Film Administration hosted a promotional event on December 28 for films scheduled to be released during the New Year’s season, showcasing a variety of genres including comedy, action, suspense, and romance [3] - Key films highlighted include "Family Reunion," which tells a heartwarming story of an old landlord and a tenant forming a temporary family, "In the Line of Duty," focusing on a kidnapping survival story, and "Hidden Kill," which follows an artist and police investigating a series of cases [3]

Core Viewpoint - The film industry is experiencing a rebound, with Huayi Brothers seeing a rise of over 10% in stock price, alongside other companies in the sector such as Jinyi Films, Happiness Blue Sea, Hengdian Film, and Bona Film [1] Group 1: Industry Performance - The film sector showed signs of recovery with significant stock price increases among key players [1] - As of December 28, 2025, the total box office for the holiday season (November 28 to December 31) reached 5.245 billion yuan, including pre-sales [1]

Core Viewpoint - The film and cinema sector saw a rise of 1.01% on December 26, with notable gains from companies like Baida Qiancheng, which surged by 20.08% [1] Group 1: Market Performance - The Shanghai Composite Index closed at 3963.68, up 0.1%, while the Shenzhen Component Index closed at 13603.89, up 0.54% [1] - Baida Qiancheng led the gains in the film and cinema sector, closing at 6.40 with a rise of 20.08% and a trading volume of 79,000 shares, amounting to 50.58 million yuan [1] - Other notable performers included Happiness Blue Sea, which rose by 3.51% to 20.07, and Bona Film, which increased by 1.39% to 8.05 [1] Group 2: Capital Flow - The film and cinema sector experienced a net inflow of 67.36 million yuan from institutional investors, while retail investors contributed a net inflow of 33.60 million yuan [2] - Conversely, there was a net outflow of 101 million yuan from speculative funds [2] - The individual stock capital flow showed that Baida Qiancheng had a net inflow of 27.99 million yuan from institutional investors, while it faced a net outflow of 12.34 million yuan from speculative funds [3]

（文章来源：证券日报） 证券日报网讯 12月22日，幸福蓝海发布公告称，公司第五届董事会第十五次会议审议通过《关于聘任 公司高级管理人员的议案》等。 ...

Group 1 - Rongchang Biotech plans to repurchase shares worth between 20 million and 40 million yuan, with a maximum price of 95 yuan per share, aiming to buy back approximately 21,050 to 42,110 shares, representing about 0.04% to 0.07% of total share capital [1] - Nanya New Materials intends to raise no more than 900 million yuan through a private placement for AI computing power-based high-frequency high-speed copper-clad laminate R&D and working capital [2] - Xiechuang Data has signed a strategic cooperation agreement with Ping An Financial Leasing, aiming for a cooperation scale of 2 billion yuan over three years [3] Group 2 - Chuangshi Technology's controlling shareholder is under investigation and has been placed under detention, having resigned from all positions in the company [4] - Deep Kangjia A has reported overdue shareholder loans to Yikang Technology and Chuzhou Kangxin, totaling approximately 233 million yuan and 395 million yuan respectively, due to repayment issues [5] - Ningbo Yuanyang announced the resignation of two directors due to work adjustments [6] Group 3 - China Merchants Energy has delivered the world's first methanol dual-fuel VLCC oil tanker, with 15 oil tanker orders in hand [7] - Tianyu Co., Ltd. has received a drug registration certificate for hydrochloride trazodone tablets, which are used for treating depression [8] - Haizheng Pharmaceutical has received FDA approval for clinical trials of HS387 tablets for treating advanced solid tumors [9] Group 4 - Warner Pharmaceuticals has obtained a drug registration certificate for isoproterenol hydrochloride injection, used for treating shock and complete atrioventricular block [10] - Hekang New Energy's subsidiary received a government subsidy of 1.5 million yuan, which accounts for 14.57% of the company's latest audited net profit [11] - Duku Culture is planning a change in company control, with stock suspension expected for no more than two trading days [12] Group 5 - Haisco has received acceptance for an IND application for HSK46575 tablets for prostate cancer treatment [13] - *ST Xinyan is executing a capital reserve transfer to increase share capital, resulting in a stock suspension [14] - Nanjing Public Utilities is transferring a 45% stake in a subsidiary for 23.6443 million yuan [15] Group 6 - Action Education plans to repurchase shares worth between 20 million and 25 million yuan, with a maximum price of 45 yuan per share [16] - Bai'ao Tai has received government subsidies totaling 29 million yuan [18] - Weisi Medical intends to sell assets worth 119 million yuan, expecting a profit impact of approximately 10 million yuan [19] Group 7 - Tongyu Communications plans to increase capital by 10 million yuan to introduce investment from Wuchuang Institute [20] - Dongtu Technology's subsidiary is introducing strategic investor Guofeng Investment Fund with a capital increase of 11 million yuan [21] - China General Nuclear Power Technology's shareholder is facing a judicial auction of 2.91% of the company's shares [22] Group 8 - Nanshan Aluminum plans to repurchase shares worth between 300 million and 600 million yuan, with a maximum price of 7.52 yuan per share [23] - Yipin Hong's controlling shareholder has committed to transferring 9.07% equity in Arthrosi without compensation [24] - Sanli Pharmaceutical has signed a technology transfer contract worth 200 million yuan with Hainan University [25] Group 9 - Xin Nuo Wei plans to jointly invest 450 million yuan with Zhongqi Pharmaceutical to establish a joint venture focusing on innovative metabolic drugs [26] - Li Qun Co. has been approved to issue 1 billion yuan in medium-term notes to optimize debt structure and supplement working capital [27] - Dongfang Ocean's subsidiary has received a medical device registration certificate for a procalcitonin test kit [28] Group 10 - Tibet Mining's chairman has resigned due to work adjustments [29] - Wantai Biological's subsidiary has been shortlisted for a national immunization program vaccine procurement project, with a bid price of 27.5 yuan [30] - Xingfu Blue Sea has appointed Zhang Chen as the new deputy general manager [31] Group 11 - Changyuan Donggu has elected Li Yixuan as the vice chairman of the board [32] - Ningbo Huaxiang's subsidiary has signed a strategic cooperation agreement with Dahuang Robotics for collaboration in humanoid robot development [33] - Yongda Co. has been pre-selected for a procurement project worth approximately 350 million yuan [34] Group 12 - Fuan Pharmaceutical's subsidiary has received a drug registration certificate for hydrochloride trazodone tablets [35] - Nanjing Food reported a 71.03% year-on-year decrease in net profit for November due to rising raw material costs [36] - Changqing Technology's special polymer monomer project has commenced production [37]

关于调整公司组织架构的公告 证券代码：300528 证券简称：幸福蓝海 公告编号：2025-066 幸福蓝海影视文化集团股份有限公司 调整后的公司组织架构图见附图。 特此公告。 幸福蓝海影视文化集团股份有限公司董事会 2025年12月22日 股东会 战略委员会 提名委员会 董事会 薪酬与考核委员会 审计委员会 总经理(经营管理层) 行 法 战 数 内 董 财 务 控 事 务 智 略 政 会 办公 人事 资 广 部 品 科 宙 计 lg 牌 部 部 部 部 部 室 T ] 北 江 江 江 江 江 江 江 京 赤 苏 赤 赤 赤 苏 苏 广告分 主 福 幸福 猫 キ 福 溢 天 幸福 猫 幸 盛 世 版 地 影 纵 海 海 海 海 视 横 海 公 院 影 影 传 文 影 中 司 线 天 개 院 化 视 媒 有 有 有 龙影 发 有 文 限 限 化 限 展 限 投 责 责 责 视 有 公 资 任 限 任 司 文 任 责 公 有 化 公 公 任 限 有 司 司 司 限 公 公 责 司 司 tt 公 司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 为确保公司持续高效 ...

证券代码：300528 证券简称：幸福蓝海 公告编号：2025-065 附相关人员简历： 张晨：男，1985 年 6 月出生，中国国籍，无永久境外居留权，大学本科学 历。2008 年 7 月起至江苏省广播电视集团有限公司工作，2016 年 3 月至 2019 年 2 月任江苏省广播电视集团有限公司地面频道广告营销中心副主任，2019 年 2 月至 2020 年 6 月任江苏省广播电视集团有限公司卫视频道综合管理中心商务开 发部主任，2020 年 6 月起至今任江苏省广播电视集团有限公司卫视频道商务推 广中心副主任。 关于聘任公司高级管理人员的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 幸福蓝海影视文化集团股份有限公司（以下简称"公司"）于 2025 年 12 月 22 日召开的第五届董事会第十五次会议审议通过了《关于聘任公司高级管理人 员的议案》。根据《公司法》等相关法律法规及公司章程的规定，结合公司实际 经营管理需要，经公司副董事长兼总经理张烨镝先生提名及提名委员会审议，公 司董事会同意聘任张晨先生为公司副总经理，任职期限自公司董事会审议通过之 日 ...

证券代码：300528 证券简称：幸福蓝海 公告编号：2025-064 幸福蓝海影视文化集团股份有限公司 第五届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 幸福蓝海影视文化集团股份有限公司（以下简称"公司"）第五届董事会第 十五次会议通知于 2025 年 12 月 10 日以邮件和电话的方式发出。会议于 2025 年 12 月 22 日上午 09:00 在南京市栖霞区元化路 8 号 28 幢（仙林南大科学园智 慧园 6 号 C 栋 3 楼）公司 C310 会议室以通讯表决方式召开。会议应参与表决董 事 9 人，实际参与表决董事 9 人。会议由董事长任桐主持，公司高级管理人员及 相关中介机构人员列席了会议。本次会议的召集、召开和表决程序符合有关法律、 法规和《公司章程》的规定，会议形成的决议合法有效。 二、董事会会议审议情况 本次会议以记名方式投票表决，审议通过以下事项： 1.审议通过《关于聘任公司高级管理人员的议案》 为了进一步加强公司经营管理，经公司副董事长兼总经理张烨镝先生提名, 董事会同意聘任张晨先 ...